Eur J Nucl Med Mol Imaging

2016

DOI: 10.1007/s00259-016-3375-8

|View full text |Cite

|

Sign up to set email alerts

|

Erratum to: Quantitative assessment of atherosclerotic plaques on 18F-FDG PET/MRI: comparison with a PET/CT hybrid system

¹

,

²

,

³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction3

Citation Types

Supporting

0

Mentioning

3

Contrasting

0

Year Published

2020

2020

2023

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

0

Mentioning

3

Contrasting

0

Order By: Relevance

“…Traditional methods for diagnosing or detecting atherosclerosis include intravascular ultrasound (IVUS), optical coherence tomography (OCT) and positron emission tomography (PET), in addition to routine blood tests. [4,43,[47][48][49] Although the above imaging techniques can provide a comprehensive and detailed assessment of vascular thickness, stenosis and plaque, however, its extensive clinical application is limited due to its strong invasiveness. Intravascular magnetic resonance imaging (IVMRI), with its high spatial resolution and signal-to-noise ratio, can be applied to noninvasive in vivo imaging of atherosclerosis, but these methods are based on plaque already clearly forming.…”

Section: Introductionmentioning

confidence: 99%

“…A number of sensors have been developed for noninvasive visualization of atherosclerosis. Traditional methods for diagnosing or detecting atherosclerosis include intravascular ultrasound (IVUS), optical coherence tomography (OCT) and positron emission tomography (PET), in addition to routine blood tests [4,43,47–49] . Although the above imaging techniques can provide a comprehensive and detailed assessment of vascular thickness, stenosis and plaque, however, its extensive clinical application is limited due to its strong invasiveness.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Detection and Imaging of Active Substances in Early Atherosclerotic Lesions Using Fluorescent Probes

¹

,

²

,

³

et al. 2023

View full text Add to dashboard Cite

Atherosclerosis (AS) is a vascular disease caused by chronic inflammation and lipids that is the main cause of myocardial infarction, stroke and other cardiovascular diseases. Atherosclerosis is often difficult to detect in its early stages due to the absence of clinically significant vascular stenosis. This is not conducive to early intervention or treatment of the disease. Over the past decade, researchers have developed various imaging methods for the detection and imaging of atherosclerosis. At the same time, more and more biomarkers are being found that can be used as targets for detecting atherosclerosis. Therefore, the development of a variety of imaging methods and a variety of targeted imaging probes is an important project to achieve early assessment and treatment of atherosclerosis. This paper provides a comprehensive review of the optical probes used to detect and target atherosclerosis imaging in recent years, and describes the current challenges and future development directions.

“…Traditional methods for diagnosing or detecting atherosclerosis include intravascular ultrasound (IVUS), optical coherence tomography (OCT) and positron emission tomography (PET), in addition to routine blood tests. [4,43,[47][48][49] Although the above imaging techniques can provide a comprehensive and detailed assessment of vascular thickness, stenosis and plaque, however, its extensive clinical application is limited due to its strong invasiveness. Intravascular magnetic resonance imaging (IVMRI), with its high spatial resolution and signal-to-noise ratio, can be applied to noninvasive in vivo imaging of atherosclerosis, but these methods are based on plaque already clearly forming.…”

Section: Introductionmentioning

confidence: 99%

“…A number of sensors have been developed for noninvasive visualization of atherosclerosis. Traditional methods for diagnosing or detecting atherosclerosis include intravascular ultrasound (IVUS), optical coherence tomography (OCT) and positron emission tomography (PET), in addition to routine blood tests [4,43,47–49] . Although the above imaging techniques can provide a comprehensive and detailed assessment of vascular thickness, stenosis and plaque, however, its extensive clinical application is limited due to its strong invasiveness.…”

Section: Introductionmentioning

confidence: 99%

Detection and Imaging of Active Substances in Early Atherosclerotic Lesions Using Fluorescent Probes

¹

,

²

,

³

et al. 2023

View full text Add to dashboard Cite

Atherosclerosis (AS) is a vascular disease caused by chronic inflammation and lipids that is the main cause of myocardial infarction, stroke and other cardiovascular diseases. Atherosclerosis is often difficult to detect in its early stages due to the absence of clinically significant vascular stenosis. This is not conducive to early intervention or treatment of the disease. Over the past decade, researchers have developed various imaging methods for the detection and imaging of atherosclerosis. At the same time, more and more biomarkers are being found that can be used as targets for detecting atherosclerosis. Therefore, the development of a variety of imaging methods and a variety of targeted imaging probes is an important project to achieve early assessment and treatment of atherosclerosis. This paper provides a comprehensive review of the optical probes used to detect and target atherosclerosis imaging in recent years, and describes the current challenges and future development directions.

“…Angiography has long been a gold standard for diagnosing vascular disease, but it is traumatic and expensive (6). As technology moves forward, the non-invasive detection of carotid atherosclerosis is now increasingly popular in clinical practice (7). Observing the carotid artery from different aspects and different levels, computed tomography (CT) has better practicability in displaying vascular structure and stenosis (8).…”

Section: Introductionmentioning

confidence: 99%

Comparison of Predictive Ability of Computed Tomography and Magnetic Resonance Imaging in Patients with Carotid Atherosclerosis Complicated with Stroke

Chen²,

et al. 2020

View full text Add to dashboard Cite

Background: To investigate the characterizations of CT (computed tomography) and MRI (magnetic resonance imaging) in patients with carotid atherosclerosis. Methods: A retrospective analysis was performed on the medical records of 264 patients with carotid atherosclerosis underwent CT and MRI in Linyi Central Hospital, Linyi, China from January 2010 to January 2016. Among them, 142 patients with ischemic stroke were in experimental group (test group), another 122 patients in control group. The lumen stenosis degree, plaque fibrous cap status, calcification information and vascular plaque hemorrhage in the carotid artery fork of patients detected by CT and MRI were collected. Results: The detection rate of the plaque calcification of patients detected by MRI was lower than that detected by CT in the experimental group (P<0.05). Patients in the experimental group had higher average vascular stenosis degree detected by CT and MRI than those in the control group (P<0.01). The average vascular stenosis degree of patients detected by MRI was higher than that detected by CT in the experimental group (P<0.05). Patients in the experimental group had higher unstable fibrous cap number detected by CT and MRI than those in the control group (P<0.01). Patients in the experimental group had significantly higher number of vascular plaque small focus hemorrhage than those in the control group (P<0.05). Conclusion: Patients with carotid atherosclerotic complicated with stroke have higher plaque calcification number, vascular stenosis degree and unstable fibrous cap number. Both CT and MRI can better predict the risk of stroke.

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product

Browser Extension Assistant by scite Citation Statement Search Reference Check Visualizations Dashboards Explore Journals Explore Organizations Explore Funders Embedding Badge Embedding Citation Search Pricing

Resources

Blog Help & FAQ Accessibility Statement API Terms For Universities & Governments For Researchers For Publishers For Corporate, Pharma & Enterprise Author Marketing Become an Affiliate Get an organization trial or quote scite Data & Services

About

News & Press Careers Read our Paper Coverage

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.